Entrada Therapeutics Stock (NASDAQ: TRDA)

Dernières nouvelles pour Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics Inc

SXTC

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

On Monday, Elon Musk expressed his frustration over the perceived incompetence of federal workers and misuse of taxpayer money in a post on X. 
What Happened: Musk, who is associated with the Department of Government Efficiency, criticized the inability of some employees to pass a <a href="https://www.benzinga.com/news/25/02/43902918/elon-musk-demands-federal-workers-justify-their-jobs-fbis-kash-patel-tells-employees-not-to-respond">simple email test</a>, which he deemed as a display of contempt for how taxes are being spent.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The email request was utterly trivial, as the standard for passing the test was to type some words and press send! Yet so many failed even that inane test, urged on in some cases by their managers. Have you ever witnessed such INCOMPETENCE and CONTEMPT for how YOUR TAXES are… <a href="https://t.co/QjSmY4ezpg">https://t.co/QjSmY4ezpg</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1894173297786720718?ref_src=twsrc%5Etfw">February 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This post comes in the wake of Musk&#8217;s demand that federal employees justify their positions to him via email or risk losing their jobs. This directive, according to Musk, aligns with President Donald Trump&#8217;s instructions to eradicate federal waste and fraud. However, this move has been met with resistance, with FBI&#8217;s Kash Patel advising employees not to respond to Musk&#8217;s request.
Musk said that subject to the discretion of Trump, Federal employees would be &#8220;given another chance.&#8221; Responding to the right-wing political commentator Matt Walsh, he said, &#8220;Failure to respond a second time will result in termination.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Subject to the discretion of the President, they will be given another chance. Failure to respond a second time will result in termination. <a href="https://t.co/04xzgScXfj">https://t.co/04xzgScXfj</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1894177129887404484?ref_src=twsrc%5Etfw">February 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/personal-finance/25/02/43929806/dave-ramsey-says-its-very-difficult-to-trust-someone-in-pajamas-on-a-zoom-call-admits-hes-the-crotchety-old-boss">Dave Ramsey Says &#8216;It&#8217;s Very Difficult To Trust Someone In Pajamas On A Zoom Call&#8217;—Admits He&#8217;s &#8216;The Crotchety Old Boss&#8217;</a>
Why It Matters: Musk&#8217;s role as a senior advisor to Trump has been under legal scrutiny, with allegations of him exercising &#8220;virtually unchecked power&#8221;. The Trump administration clarified that Musk is <a href="https://www.benzinga.com/news/25/02/43902918/elon-musk-demands-federal-workers-justify-their-jobs-fbis-kash-patel-tells-employees-not-to-respond">not a part of the DOGE</a> team but serves as a senior advisor to the President. This clarification comes as the Trump administration faces a lawsuit alleging Musk's influence is excessive for a non-elected, non-Senate-confirmed individual.
A lawsuit filed by several Democratic states seeks to restrict Musk and the DOGE team from accessing government systems, arguing that Musk's influence contravenes the Constitution. The Trump administration, however, maintains that Musk is not a DOGE employee and does not have the authority to make government decisions himself.
Musk&#8217;s recent post and his demands on federal workers are likely to fuel this ongoing controversy. His demand that federal employees submit work summaries or be considered resigned faced swift pushback from agency heads and lawmakers, leading the Trump administration to clarify that responses were voluntary. While Trump defended Musk's move as an efficiency measure, even some Republican senators criticized it as overreach, <a href="https://thehill.com/homenews/administration/5161948-trump-musk-opm-email-backlash/">reported</a> The Hill.
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Government

News

Politics

General

Elon Musk Says DOGE Email Request To Federal Workers Utterly Trivial: 'Failure To Respond A Second Time Will Result In Termination'

Dave Ramsey is doubling down on his stance against remote work, joining the ranks of <a href="https://www.benzinga.com/news/25/01/43306967/elon-musk-slams-work-from-home-as-messed-up-and-morally-wrong-meanwhile-remote-workers-quietly-sneak-in-three-day-weekends-every-week">Elon Musk</a> and <a href="https://www.benzinga.com/markets/equities/25/02/43757032/jamie-dimon-goes-off-on-return-to-office-critics-you-dont-have-to-work-at-jpmorgan">Jamie Dimon</a>, explicitly saying that in-person collaboration is the key to success.&nbsp;
On a recent episode of the &#8220;EntreLeadership&#8221; <a href="https://www.youtube.com/watch?v=wuu7_xBcFDI">podcast</a>, Ramsey talked with a business owner who was worried about employees skipping lunch to leave work early. This led to a bigger conversation about workplace rules, leadership, and his strong opinion on remote work.
Don't Miss:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
<h2 class="wp-block-heading">The Case Against Remote Work</h2>
Ramsey, the well-known personal finance guru and business leader, was direct when talking about the efficiency of remote work. &#8220;We know things move at the speed of trust, and it&#8217;s very difficult to trust someone sitting in their pajamas on a Zoom call,&#8221; he said.
He explained that at Ramsey Solutions, employees are <a href="https://www.benzinga.com/24/07/39945751/bosses-admit-using-return-to-office-mandate-to-get-workers-to-quit-survey">expected to work from the office</a> because it improves communication, creativity, and productivity. While he acknowledged that working from home isn&#8217;t &#8220;morally wrong,&#8221; he argued that it simply isn&#8217;t as effective as in-person collaboration.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
His comments reflect a broader debate among business owners about the pros and cons of remote work. Some companies have embraced flexibility, while others, like Ramsey Solutions, insist that employees are more productive and engaged when they work in a shared space.
Ramsey also admitted that his stance has led some employees to quit. &#8220;I&#8217;ve had some people that said they wanted to work from home, and so they quit and went to work for somebody who wanted to work from home,&#8221; he said. &#8220;Which I guess makes me the crotchety old boss in this scenario, right?&#8221;
Despite acknowledging that his views aren&#8217;t popular with everyone, he stood by his belief that workplace structure is a key part of running a successful business. &#8220;It is my name on the side of the building, and it is my signature on the bottom of your freaking paycheck,&#8221; he stated.
See Also: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
Ramsey's remarks highlight the challenges many business owners face when balancing employee preferences with business needs. His message is that company culture and expectations should be firmly established, and employees who disagree have the option to seek work elsewhere.
His advice to the business owner on the podcast was to address the issue directly and set precise expectations for employees, telling them that he let this situation go unchecked for a while, which created a gap in their customer service. He should also tell them he has regrets about not addressing it sooner because now it might seem like he&#8217;s reversing his stance, but that's not the case.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Personal Finance

Dave Ramsey Says 'It's Very Difficult To Trust Someone In Pajamas On A Zoom Call'—Admits He's 'The Crotchety Old Boss'

Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) has outperformed the market over the past 20 years by 4.4% on an annualized basis producing an average annual return of 12.7%. Currently, Raymond James Finl has a market capitalization of $31.08 billion. 
Buying $1000 In RJF: If an investor had bought $1000 of RJF stock 20 years ago, it would be worth $10,952.50 today based on a price of $151.68 for RJF at the time of writing.
<h3>Raymond James Finl's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740440711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) is set to report its fourth-quarter results after Tuesday's closing bell. Here's a look at what to <a href="https://www.benzinga.com/content/43900819/these-4-low-pe-tech-stocks-could-be-breakout-ready-bargains">expect in the report. </a>
What To Watch: Investors will be looking for updates on First Solar's net bookings which were 4.0 GW year-to-date last quarter and only 0.4 GW growth in the third quarter.&nbsp;
Wall Street will also be interested in the company's guidance heading into fiscal 2025. First Solar lowered its<a href="https://www.benzinga.com/news/earnings/24/10/41613167/first-solar-stock-sinks-after-worse-than-expected-q3-results-cut-fy24-guidance"> fiscal 2024</a> net sales forecast to a range of $4.1 billion to $4.25 billion, versus the $4.44 billion estimate, last quarter.&nbsp;
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/02/43920295/palantir-extends-losses-microsoft-slides-whats-driving-markets-monday">Palantir Extends Losses, Microsoft Slides: What&#8217;s Driving Markets Monday?&nbsp;</a>
The company also lowered its full-year earnings forecast from between $13 and $14 per share to between $13 and $13.50 per share, versus the $13.49 estimate.
First Solar executives may provide commentary on the political climate and new Energy Secretary Chris Wright, whose background in the fossil fuel industry and his views on climate change and renewable energy could be of concern.&nbsp;
Analysts Weigh In: First Solar stock has a consensus price target of $278.71 based on the ratings of 25 analysts.&nbsp; The high is $367, issued by Morgan Stanley in November 2024 and the low is $209, issued by Wells Fargo on Jan. 8, 2025.&nbsp;
Mizuho analyst Maheep Mandloi upgraded First Solar shares from Neutral to Outperform and raised the price target from $218 to $259 in mid-February.&nbsp;
According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect the company to report quarterly earnings of $4.71 per share on revenue of $1.47 billion.&nbsp;
FSLR Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, First Solar shares ended Monday's session down 1.63% at $152.91.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">Financial Crime Weekly: $1.4 Billion Ethereum Stolen In Largest Crypto Hack Ever, SEC Creates Cyber And Emerging Technologies Unit</a></li>
</ul>
Image: Shutterstock

Earnings

Previews

Tech

FSLR

First Solar Q4 Earnings Preview: Sales, Net Bookings To Watch

Republic Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>) has outperformed the market over the past 5 years by 43.8% on an annualized basis producing an average annual return of 58.85%. Currently, Republic Servs has a market capitalization of $72.67 billion. 
Buying $1000 In RSG: If an investor had bought $1000 of RSG stock 5 years ago, it would be worth $10,709.16 today based on a price of $232.71 for RSG at the time of writing.
<h3>Republic Servs's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740439809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Republic Servs Stock In The Last 5 Years

TD Cowen analyst Andrew Charles maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Buy and maintains $490 price target.

Price Target

Analyst Ratings

TD Cowen Maintains Buy on Domino's Pizza, Maintains $490 Price Target

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares traded higher Monday following reports that multiple lenders are preparing to back a <a href="https://www.benzinga.com/general/health-care/25/02/43791793/why-is-walgreens-boots-alliance-stock-trading-higher-on-tuesday">potential buyout from</a><a href="https://www.benzinga.com/general/health-care/25/02/43791793/why-is-walgreens-boots-alliance-stock-trading-higher-on-tuesday"> Sycamore Partners</a>.
What To Know: Morgan Stanley, UBS and private lenders are reportedly putting together a $10 billion package to back Sycamore Partners&#8217; potential takeover deal for Walgreens, according to a <a href="https://x.com/OctusCredit/status/1894084066774863917">post</a> from Octus on Monday.
Sources familiar with the matter said the deal could be separated into multiple tranches and nothing has been formalized yet.
Walgreens Boots Alliance shares are up approximately 16% since the start of the year, buoyed by buyout rumors. Bloomberg<a href="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive?embedded-checkout=true"> reported</a> last week that Walgreens shares were up after CNBC&#8217;s David Faber said the deal was still &#8220;alive&#8221; after being "mostly dead a couple of weeks ago.&#8221;
The news follows <a href="https://www.benzinga.com/24/12/42421855/walgreens-stock-jumps-on-report-of-potential-private-equity-sale-what-you-need-to-know">reports</a> from December that indicated Walgreens was discussing a deal with Sycamore Partners in which the company would sell itself to the private-equity firm and pull the pharmacy chain from public markets.
Walgreens shares have been trending lower for the past 10 years. The stock was trading above $90 per share and valued at more than $100 billion in 2015. Walgreens had a market cap of $8.78 billion as of Monday's close, per <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
See Also: <a href="https://www.benzinga.com/general/health-care/25/02/43926641/hims-hers-health-stock-drops-after-q4-report-eps-in-line-revenues-beat">Hims &amp; Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat</a>
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> closed Monday up 6.31% at $10.80, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

Walgreens Boots Alliance Stock Is Up More Than 6% On Monday: Here's What Happened

DA Davidson analyst Linda Bolton Weiser maintains Hasbro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) with a Neutral and raises the price target from $73 to $75.

DA Davidson Maintains Neutral on Hasbro, Raises Price Target to $75

A new book from Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) CEO and co-founder Alex Karp has a unique take on the company's role and how Silicon Valley lost its way. The timing of the book launch comes as Palantir stock has soared in the past year.
What Happened: Karp and Palantir's Head of Corporate Affairs Nicholas Zamiska co-authored the new book, "The Technological Republic: Hard Power, Soft Belief, and the Future of the West," which serves as a manifesto of sorts about the data analytics company.
In the book, Karp and Zamiska say, "Silicon Valley has lost its way," as <a href="https://techcrunch.com/2025/02/23/palantir-ceos-new-book-says-silicon-valley-has-lost-its-way/?guccounter=1">reported </a>by TechCrunch.
The book <a href="https://techrepublicbook.com/?gad_source=1&amp;gbraid=0AAAAA-5oD3wY2yT2cnjhljB0Fm1UdHSfg&amp;gclid=Cj0KCQiAq-u9BhCjARIsANLj-s3GDb2MOQ6TeLvEK0DnyL_wX06AkWQqEwpIreM1pRZsx7JtHMSobXYaAoTEEALw_wcB">dives </a>into the close relationship between technology companies in Silicon Valley and the U.S. government and how that helped with the growth of the area.
The duo said the government is now developing new technology with companies in the private sector and Silicon Valley is "focusing its energy on narrow consumer products."
Today's Silicon Valley looks different with dominance of the region belonging to online advertising and shopping, video-sharing platforms and social media, the duo writes.
"A generation of talent has been led astray. And a moment of reckoning has arrived for the West."
The book's description says items such as "timid leadership" and "intellectual fragility" have made the U.S. vulnerable to global threats.
Read Also: <a href="https://www.benzinga.com/news/management/24/09/40862198/palantir-ceo-offers-radical-take-on-national-security-touch-an-american-and-well-inflict-pain-on-">Palantir CEO Offers &#8216;Radical&#8217; Take On National Security: &#8216;Touch An American And We&#8217;ll Inflict Pain On You For Generations&#8217;</a>
Why It's Important: The book seeks to make a difference in the shift and regain the rise of Silicon Valley.
"The software industry should rebuild its relationship with government and redirect its effort and attention to constructing the technology and artificial intelligence capabilities that will address the most pressing challenges that we collectively face."
The authors say the government must also embrace the Silicon Valley mindset once again for both items to be successful.
The book's release timing comes after Donald Trump was sworn in as president in January.
Some reviewers of the book question the timing of the book and whether it came before Trump won the 2024 election.
Karp previously<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40795608/palantirs-s-p-500-journey-rebel-tech-giant-transforms-into-frankenstein-monster-powere"> addressed Palantir's unique path </a>of becoming a component of the S&amp;P 500. Karp&nbsp;<a href="https://www.youtube.com/watch?v=8o_lK7-133Q" target="_blank" rel="noreferrer noopener">emphasized&nbsp;</a>how Palantir&#8217;s unique approach, centered on building exceptional products, has been key to its success.
&#8220;We built the best products in the world. We started off in one area of the West Clandestine Services. We migrated into the military, into Spec Ops in the U.S. commercial and into us into commercial globally,&#8221; Karp explained.
Karp said some analysts thought Palantir was a "Frankenstein monster powered by a freak show leader" before becoming a profitable company.
PLTR Price Action: Palantir stock closed Monday down 10.53% at $90.68. Palantir stock is up over 280% in the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43806845/palantir-ceo-alex-karp-backs-elon-musks-government-efficiency-efforts-calls-him-most-important-builder">Palantir CEO Alex Karp Backs Elon Musk&#8217;s Government Efficiency Efforts, Calls Him &#8216;Most Important Builder&#8217;</a></li>
</ul>
Photos: Courtesy Crown Currency; Shutterstock

Entertainment

Management

PLTR

Palantir CEO Alex Karp Has New Book Out About Silicon Valley: 'A Moment Of Reckoning Has Arrived For The West'

Barrington Research analyst Alexander Paris maintains Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) with a Outperform and raises the price target from $20 to $22.

LINC

Barrington Research Maintains Outperform on Lincoln Educational Servs, Raises Price Target to $22

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 10.38% on an annualized basis producing an average annual return of 21.34%. Currently, Veeva Systems has a market capitalization of $36.71 billion. 
Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,296.22 today based on a price of $226.11 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740438912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VEEV

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Barrington Research analyst Gary Prestopino maintains LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) with a Outperform and maintains $60 price target.

Barrington Research Maintains Outperform on LKQ, Maintains $60 Price Target

Guidance

Ziff Davis Expects FY25 Revenue Of $1.442B - $1.502B (Est $1.493B), Adj EPS Of $6.64 - $7.28 (Est $7.39)

Douglas Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) is looking for FY2025 Adj EPS of $1.30-$2.10 vs $1.93 analyst estimate. sees sales of $610.000 million-$650.000 million vs $621.43 million analyst estimate.

PLOW

Douglas Dynamics Sees FY2025 Adj EPS $1.30-$2.10 vs $1.93 Est; Sees Sales $610.000M-$650.000M vs $621.43M Est

Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) reported quarterly earnings of $2.58 per share which missed the analyst consensus estimate of $2.63 by 1.9 percent. This is a 10.73 percent increase over earnings of $2.33 per share from the same period last year. The company reported quarterly sales of $412.82 million which missed the analyst consensus estimate of $424.46 million by 2.74 percent. This is a 5.88 percent increase over sales of $389.88 million the same period last year.

Earnings Misses

Ziff Davis Q4 2024 Adj EPS $2.58 Misses $2.63 Estimate, Sales $412.82M Miss $424.46M Estimate

Douglas Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.31 by 25.81 percent. This is a 105.26 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $143.55 million which missed the analyst consensus estimate of $155.23 million by 7.53 percent. This is a 6.93 percent increase over sales of $134.25 million the same period last year.

Earnings Beats

Douglas Dynamics Q4 Adj $0.39 Beats $0.31 Estimate, Sales $143.55M Miss $155.23M Estimate

TFII

TFI International Plans To Remain A Canadian Corporation; Not To Pursue Its Previously-announced Intention To Re-domicile From Canada To US

Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) has outperformed the market over the past 20 years by 1.57% on an annualized basis producing an average annual return of 9.9%. Currently, Constellation Brands has a market capitalization of $32.27 billion. 
Buying $100 In STZ: If an investor had bought $100 of STZ stock 20 years ago, it would be worth $664.33 today based on a price of $178.57 for STZ at the time of writing.
<h3>Constellation Brands's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740438009_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Constellation Brands Stock In The Last 20 Years

Black Stone Minerals Expects 2025 Royalty Production To Increase By 2% YoY

Press Releases

Entrada Therapeutics Reports Second Quarter 2024 Financial Results

Health Care

Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program

āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors

Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development

Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society

Entrada Therapeutics Reports Third Quarter 2024 Financial Results

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Azenta Announces the Election of Dipal Doshi to its Board of Directors

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy

Comments

Entrada Therapeutics

Actualités

Dernières nouvelles pour Entrada Therapeutics (NASDAQ:TRDA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL